Sigma Planning Corp’s Aethlon Medical AEMD Stock Holding History

Sigma Planning Corp’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-14	Closed	-$28K	–	1328
2020 Q4	$28K	Sell	14 -3	-18%	-$4.01K	﹤0.01%	1182
2020 Q3	$19K	Sell	17 -7	-29%	-$9.48K	﹤0.01%	1051
2020 Q2	$39K	Buy	24 +5	+26%	+$6.04K	﹤0.01%	1031
2020 Q1	$23K	Buy	+19	New	+$32.2K	﹤0.01%	899

Other funds holding AEMD

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

FMBTD

First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Sigma Planning Corp's AEMD Position: Q1 2021 in Review

Sigma Planning Corp sold out of Aethlon Medical (AEMD) in Q1 2021, closing a stake of 14 shares — an estimated $28K sold.

Sigma Planning Corp first reported a position in AEMD in Q1 2020 and held it in 4 quarters. The position peaked at $39K in Q2 2020. 18 funds tracked by Wall St. Rank hold AEMD as of Q1 2021.

Sigma Planning Corp reported no remaining Aethlon Medical position as of Q1 2021 after selling out during the quarter.
Sigma Planning Corp sold 14 Aethlon Medical shares in Q1 2021, an estimated $28K.
Sigma Planning Corp first reported a position in Aethlon Medical in Q1 2020 and held it in 4 quarters.
Sigma Planning Corp's Aethlon Medical position peaked at $39K in Q2 2020.
18 funds tracked by Wall St. Rank held Aethlon Medical as of Q1 2021.

Based on Sigma Planning Corp's 13F filing for Q1 2021, filed 6 May 2021.